Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles
NEUROLOGY 2005;64:586-587
© 2005 American Academy of Neurology

February 22 Highlights

Long-term effects of migraine on cognitive function

Gaist et al. established headache diagnoses in a large population-based sample of middle-aged Danish twins. Cognitive scores of the 536 identified migraineurs were comparable to those of non-migraineurs. A lifetime diagnosis of migraine was not associated with cognitive deficits.

see page 600

The editorial by Elkind and Scher notes that many investigators have concluded that MRI signal abnormalities represent sequelae of ischemia in migraineurs. This negative study should be reassuring to clinicians and patients. However, the limited sample of cognitive tests may not best reflect deficits expected in migraine. Neuropsychological tests of visual perceptual processing should be included in subsequent studies. Moreover, if negative effect of migraine on cognitive function was more evident at older ages, this study would not have detected such a difference.

see page 590

1H-MRS changes in familial hemiplegic migraine

Dichgans et al. found regionally distinct metabolic abnormalities in the cerebellum of patients with familial hemiplegic migraine (FHM) type 1 caused by mutations in the CACNA1A gene. Cerebellar atrophy and atrophy-corrected N-acetyl aspartate (NAA) levels (an indicator of neuronal impairment) correlated with clinical cerebellar scores.

see page 608

The editorial by Benatar and Ford notes that these findings provide in vivo evidence for regionally distinct effects of mutant calcium channels. Clinical relevance of these findings is underscored by the association between the reduction in NAA levels and the degree of cerebellar dysfunction. This study highlights the value of magnetic resonance spectroscopy for exploring the pathophysiology of FHM.

see page 592

Migraine with aura and cardiovascular risk factors

In a large population-based cohort study by Scher et al., migraine sufferers particularly those with aura had a higher risk profile for cardiovascular disease compared to nonmigraineurs.

see page 614

IFN-ß-1b is effective in Japanese RRMS patients including the optic-spinal variant

Multiple sclerosis (MS) is different in Japanese patients compared with white patients in that demyelination is more likely to be restricted to the optic nerves and spinal cord and CSF IgG oligoclonal bands are less common. Saida et al. report that interferon beta-1b (IFNß-1b) reduced relapse rates and MRI changes in Japanese patients with relapsing-remitting MS, and was comparably effective in optic spinal-MS and classical-MS. These results suggest that common pathogenesis and therapeutic response to interferon despite apparent racial/genetic differences in disease characteristics.

see page 621

The editorial by Brian Weinshenker discusses the differences between "optic-spinal" (including neuromyelitis optica) and classical forms of MS in more detail, focusing on the diagnostic, genetic, and therapeutic implications.

see page 594

Clinical diagnosis of MM2 type sporadic CJD

Brain MRI, SPECT, and PET are important in the diagnosis of Creutzfeldt-Jakob disease (CJD). Hamaguchi et al. showed that hyperintense cortical signals on diffusion-weighted imaging of MRI are useful for the cortical form, and thalamic hypoperfusion or hypometabolism on SPECT or PET for the thalamic form.

see page 643

The potential to improve tPA use for stroke

Based on a prospective study by S. Claiborne Johnston of all patients treated for ischemic stroke at 11 hospitals in California, it was found that calls to 911 at symptom onset should have a much greater impact on rates of thrombolytic treatment than providing perfect in-hospital care or extending the time window to 6 hours.

see page 654

Exercise protection against Parkinson disease

In a large prospective cohort study, Chen et al. found that men with regular physical activity have a lower risk of PD than their more sedentary peers. No such relation was found among women.

see page 664

Driving licensing in patients with controlled epilepsy

In a 40-year follow-up study by Sillanpää and Shinnar, people with childhood-onset uncomplicated epilepsy obtained a driving license significantly less often than controls. Predictors of non-licensing were female gender, nonidiopathic epilepsy, and the presence of learning disabilities. During a short-term follow-up, there was no increase in accidents among those who were licensed.

see page 680

Cognitive anosognosia in Alzheimer disease and awareness of visuospatial and memory skills

Barrett et al. asked subjects with AD to self-estimate cognitive skills, comparing these estimates to actual test performance and control self-estimates. AD subjects overestimated visuospatial and memory skills (cognitive anosognosia) but not other cognitive domains. Controls also overestimated some skills.

see page 693

Steroid dementia: An overlooked diagnosis?

Oliver Sacks and Melanie Shulman described a remarkable elderly man who was initially diagnosed with Alzheimer disease who completely recovered cognitive function when prednisone was discontinued.

see page 707

MELAS and l-arginine therapy

In an observational study trial, Koga et al. evaluated the effects of administering l-arginine on mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS). l-Arginine improved strokelike symptoms and decreased frequency and severity of strokelike episodes.

see page 710

Coenzyme Q10 as migraine preventive

Prophylaxis in migraine is often limited by side effects. In this randomized-controlled trail, Sándor et al. showed coenzyme Q10 to be effective and well tolerated in migraine.

see page 713

Early surgery to reduce infant-onset epileptic encephalopathy

In a surgical cohort, Jonas et al. found that children with shorter seizure durations had better postsurgery developmental outcomes with or without an infantile spasm history. Children with infant-onset epilepsy from a surgically treatable lesion are at risk for epileptic encephalopathy.

see page 746


Figure. No Caption Available.


Related Articles

Migraine and cognitive function: Some reassuring news
Mitchell S.V. Elkind and Ann I. Scher
Neurology 2005 64: 590-591. [Full Text] [PDF]

Familial hemiplegic migraine: More than just a headache
Michael Benatar and Corey M. Ford
Neurology 2005 64: 592-593. [Full Text] [PDF]

Western vs optic-spinal MS: Two diseases, one treatment?
Brian Weinshenker
Neurology 2005 64: 594-595. [Full Text] [PDF]

Long-term effects of migraine on cognitive function: A population-based study of Danish twins
D. Gaist, L. Pedersen, C. Madsen, I. Tsiropoulos, S. Bak, S. Sindrup, M. McGue, B. Krogh Rasmussen, and K. Christensen
Neurology 2005 64: 600-607. [Abstract] [Full Text] [PDF]

1H-MRS alterations in the cerebellum of patients with familial hemiplegic migraine type 1
M. Dichgans, J. Herzog, T. Freilinger, M. Wilke, and D. P. Auer
Neurology 2005 64: 608-613. [Abstract] [Full Text] [PDF]

Cardiovascular risk factors and migraine: The GEM population-based study
A. I. Scher, G. M. Terwindt, H. S.J. Picavet, W. M.M. Verschuren, M. D. Ferrari, and L. J. Launer
Neurology 2005 64: 614-620. [Abstract] [Full Text] [PDF]

Interferon beta-1b is effective in Japanese RRMS patients: A randomized, multicenter study
T. Saida, K. Tashiro, Y. Itoyama, T. Sato, Y. Ohashi, Z. Zhao, and the Interferon Beta-1b Multiple Sclerosis Study Group of Japan
Neurology 2005 64: 621-630. [Abstract] [Full Text] [PDF]

Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease
T. Hamaguchi, T. Kitamoto, T. Sato, H. Mizusawa, Y. Nakamura, M. Noguchi, Y. Furukawa, C. Ishida, I. Kuji, K. Mitani, S. Murayama, T. Kohriyama, S. Katayama, M. Yamashita, T. Yamamoto, F. Udaka, A. Kawakami, Y. Ihara, T. Nishinaka, S. Kuroda, N. Suzuki, Y. Shiga, H. Arai, M. Maruyama, and M. Yamada
Neurology 2005 64: 643-648. [Abstract] [Full Text] [PDF]

Prioritizing interventions to improve rates of thrombolysis for ischemic stroke
California Acute Stroke Pilot Registry (CASPR) Investigators
Neurology 2005 64: 654-659. [Abstract] [Full Text] [PDF]

Physical activity and the risk of Parkinson disease
H. Chen, S. M. Zhang, M. A. Schwarzschild, M. A. Hernán, and A. Ascherio
Neurology 2005 64: 664-669. [Abstract] [Full Text] [PDF]

Obtaining a driver’s license and seizure relapse in patients with childhood-onset epilepsy
Matti Sillanpää and Shlomo Shinnar
Neurology 2005 64: 680-686. [Abstract] [Full Text] [PDF]

Unawareness of cognitive deficit (cognitive anosognosia) in probable AD and control subjects
Anna M. Barrett, Paul J. Eslinger, Noel H. Ballentine, and Kenneth M. Heilman
Neurology 2005 64: 693-699. [Abstract] [Full Text] [PDF]

Steroid dementia: An overlooked diagnosis?
Oliver Sacks and Melanie Shulman
Neurology 2005 64: 707-709. [Abstract] [Full Text] [PDF]

L-Arginine improves the symptoms of strokelike episodes in MELAS
Y. Koga, Y. Akita, J. Nishioka, S. Yatsuga, N. Povalko, Y. Tanabe, S. Fujimoto, and Toyojiro Matsuishi
Neurology 2005 64: 710-712. [Abstract] [Full Text] [PDF]

Efficacy of coenzyme Q10 in migraine prophylaxis: A randomized controlled trial
P. S. Sándor, L. Di Clemente, G. Coppola, U. Saenger, A. Fumal, D. Magis, L. Seidel, R. M. Agosti, and J. Schoenen
Neurology 2005 64: 713-715. [Abstract] [Full Text] [PDF]

Surgery for symptomatic infant-onset epileptic encephalopathy with and without infantile spasms
R. Jonas, R. F. Asarnow, C. LoPresti, S. Yudovin, S. Koh, J. Y. Wu, R. Sankar, W. D. Shields, H. V. Vinters, and G. W. Mathern
Neurology 2005 64: 746-750. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS